Break the cycle of chronic head pain.

Botox and oral preventives work systemically and often lose effectiveness over time. Occipital nerve stimulation (ONS) directly modulates the nerves driving your pain — addressing the source rather than the chemistry. Peer-reviewed studies show meaningful relief for chronic migraine and occipital neuralgia in patients who have not responded to medications.

Yes. Occipital neuralgia is one of the most-studied indications for peripheral nerve stimulation, with multiple peer-reviewed trials demonstrating significant pain reduction. As with all neurostimulation, you trial the device before committing — meaning you experience the relief firsthand before any permanent step.

Yes. Trigeminal neuralgia — often described as some of the most severe pain in medicine — frequently responds to radiofrequency ablation of the affected nerve branch when medications fail, with relief lasting many months and the option to repeat. Cervicogenic headache (head pain originating from the upper neck) often responds to cervical facet RFA after diagnostic blocks confirm the pain source. Both are well-suited to image-guided treatment before any invasive surgery is considered.

Radiofrequency ablation disrupts the nerve fibers carrying pain signals; effects typically last 9–18 months and can be repeated. Neurostimulation modulates ongoing signal traffic without ablation — often a more durable solution for chronic conditions. Your specialist matches the right approach to your specific pain pattern.

For chronic migraine and occipital neuralgia, ONS is supported by published research showing reduction in headache frequency, intensity, and duration. Individual response varies, which is why the trial period is so valuable — it shows you the benefit before any permanent step.

Trial lead placement is an outpatient procedure under local anesthetic and light sedation, typically 30–45 minutes. The trial period runs 5–7 days. If successful, permanent implantation is a brief outpatient procedure.

Coverage exists for chronic migraine and certain neuralgia indications when documented criteria are met. Our team verifies benefits and pursues prior authorization.

ONS is generally well-tolerated. Minor risks include lead migration, infection at the access site, or skin sensitivity over the device. Major complications are uncommon when the procedure is performed with proper imaging guidance and surgical technique.